Healthcare • Medical Devices
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if GMED is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
78 top institutions tracked
Last 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoverySentiment: neutral
Last trade: sell 29 days ago
Red flags: 9
600 filers reported a long position in GMED for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $853.8M | 10.8M | +2.9% |
| Jupiter Topco LLC | $647.9M | 8.2M | — |
| VANGUARD CAPITAL MANAGEMENT LLC | $403.5M | 5.1M | +1.5% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $394.6M | 5M | +2.4% |
| Invesco Ltd. | $340.5M | 4.3M | -0.2% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $338.1M | 4.3M | New |
| STATE STREET CORP | $293.5M | 3.7M | +3.4% |
| Sculptor Capital LP | $237M | 3M | — |
| JPMORGAN CHASE & CO | $230.8M | 2.7M | +5.7% |
| ALLIANCEBERNSTEIN L.P. | $205.1M | 2.4M | +36% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.